US Patent 11591401 Anti-CD28 compositions
Patent 11591401 was granted and assigned to Xencor on February, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11591401 Anti-CD28 compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
